KL Acquisition Corp (KLAQ) Research
Operating as a special purpose acquisition company (SPAC), KL Acquisition Corp aims to complete a business combination with one or more entities. This could take the form of a merger, asset acquisition, stock exchange, or a comparable corporate restructuring. Its investment strategy is keenly focused on the life sciences industry, particularly in medical devices, diagnostics, and life science tools and instrumentation. The company, which was founded in 2020, maintains its principal office in New York, New York.
Market snapshot
- Symbol
- KLAQ
- Price
- $10.09
- Day change
- +0.25%
- Market cap
- $70.4M
- P/E ratio
- 3.63x
- 52-week range
- 9.71-10.105
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
- Apollo Strategic Growth Capital II (APGB)
- FinTech Evolution Acquisition Group (FTEV)
- Jaws Juggernaut Acquisition Corporation (JUGG)
- Lead Edge Growth Opportunities, Ltd (LEGA)
- Levere Holdings Corp. (LVRA)
- Infinite Acquisition Corp. (NFNT)
- Silver Spike Acquisition Corp II (SPKB)
- Supernova Partners Acquisition Company III, Ltd. (STRE)
Recent insider activity
- KL Sponsor LLC — trade (7067500 shares) on 2021-01-07
- BIERMAN JAMES L — trade (30000 shares) on 2021-01-07
- Casciaro Gregory D — trade (30000 shares) on 2021-01-07
Open KL Acquisition Corp (KLAQ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.